Explore By Subject Area   

Immuno-Oncology 360°

Date: Mar 24, 2025 - Mar 26, 2025

Location: Boston, MA

Who Attends

The program is designed for all size pharma/biotech companies, academia and investors seeking to enable a patient’s immune ​​​​system to eradicate cancer.

image placeholder
image placeholder

Biopharma Responsible for

  • Cancer Immunotherapy
  • Immuno-Oncology
  • R&D Innovation & Strategy
  • Clinical R&D
  • Business Development
  • Preclinical and Translational Research
  • Biomarkers and Companion Dx
  • Early Stage Collaborations
  • Clinical Operations
  • Strategic Partnerships
  • External R&D
  • Licensing & Commercial Strategy

Solution Providers

  • Diagnostic Testing
  • Biomarkers and Companion Dx
  • Assay Development
  • Next Gen Sequencing
  • mRNA / DNA Nucleic Acid Processing
  • RNA Sequencing
  • Cell Analysis/Manufacturing Platforms
  • Liquid Biopsies
  • Cancer Genetics
  • Immune Monitoring
  • Imaging Services
  • Flow Cytometry
  • Data Analysis/Analytics
  • Laboratory Services
  • Artificial Intelligence
  • CROs/Clinical Trial Design

Investment Community Including

  • Investment Firms
  • Banks/Financial Institutions
  • Venture Capital
  • Private Equity
  • Foundation Capital
  • Analysts

Academia & Research Organizations Focusing on

  • Immuno-Oncology / Cancer Immunotherapy
  • Oncology
  • Immunology
  • Cancer Vaccines
  • Adoptive T-Cell Therapy
  • Preclinical & Clinical R&D

Professionals working in immuno-oncology business units will also benefit.

image placeholder
image placeholder
image placeholder
image placeholder

"IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"
- Jim Mansfield, PerkinElmer

image placeholder

IO360˚ is a strategic-level conference where Pharma and Biotech present along with academia and investors and hold partnering meetings so as a community we can drive faster advancements to eradicate cancer.

Immuno-Oncology 360° delivers three key benifits:

1. Access to KOLs driving the science
2. Partnership opportunities with all stakeholders in Immuno-Oncology
3. Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology

IO360° offers unparalleled business development and networking opportunities including:

Partnering/One-on-One Meetings:

• Dedicated partnering tables to connect with fellow industry professionals, investors and KOLs 
• Partnering tool to schedule partnering meetings
• Meeting times occur throughout all breaks, lunches and receptions
• Set up multiple meetings per day
• Search other attendee profiles
• Send private message to other attendees
• Dedicated partnering help desk 

Scheduled Networking: 

IO360° networking opportunities take place throughout the entire event including:
• Scheduled morning and afternooon breaks
• Lunches
• Two receptions  
• Access to the Exhibit hall 
• Early evening organized historical walks of downtown Brooklyn 

2024 Sponsors

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.